Diagnosing a Struggling MTM Program: Compliance, Workflow, and Prescriber Engagement
A three-pharmacist community pharmacy launched a Medicare Part D MTM program 12 months ago. Of 1,200 targeted beneficiaries, 240 comprehensive medication reviews (CMRs) have been completed. The pharmacist performs CMRs between dispensing tasks; the average CMR takes 22 minutes but is frequently interrupted. Documentation goes into the plan vendor's platform using the standardized personal medication list and medication action plan. Prescriber recommendations are sent by fax, and only 14% receive any response. An internal audit finds that written CMR summaries go out within the required timeframe in about half of completed cases. The same pharmacist is also the immunization lead, and the program stalled entirely for six weeks during flu season. Patient satisfaction scores are high.
1. Separate the program's problems into compliance risk, quality risk, and business risk, and rank them.
Read the worked answer
Compliance risk (highest): the written CMR summary timeline. Incomplete or late summaries put the plan's CMS obligations at risk and, by extension, the pharmacy's contract. Because CMS has revised parts of the MTM standard in recent years (including the standardized format and mailing requirements), the first action is to pull the current plan-year requirements from the plan sponsor rather than rely on memory - the fix is to build the check against the governing document, not against a remembered rule.
Quality risk (second): a 14% prescriber response rate means most identified medication-related problems never reach a decision-maker. The CMR is being performed but not closed. High patient satisfaction does not offset this - patients like the conversation; that does not mean their therapy changed.
Business risk (third): the 20% completion rate and total shutdown during flu season. The program has no capacity buffer, so any seasonal demand wipes it out. Revenue per CMR is fixed; every incomplete case is unpaid labor already spent.
Ranking rationale: compliance failures can terminate the contract; quality failures waste the work but are recoverable; capacity problems are fixable by design. Fix in that order.
2. Propose a concrete workflow redesign and a prescriber-engagement strategy, with the constraints of a three-pharmacist store.
Read the worked answer
Workflow redesign:
- Batch, do not interleave. Block 90-minute windows two afternoons per week for CMRs only; a CMR that takes 22 uninterrupted minutes is cheaper than one that takes 22 minutes spread over two hours.
- Shift pre-work to technicians: identify eligible patients, run the fill history, prepare the medication list draft, schedule the appointment, and set up the platform record. The pharmacist's time should be the clinical conversation, not the data assembly.
- Create a summary-completion checklist that is signed off before the case is closed, with a hard stop at the plan's deadline.
- Cross-train a second pharmacist so flu season removes one person, not the program.
Prescriber engagement:
- Stop treating fax as a delivery method. Ask each high-volume prescriber's office which channel they actually read - EHR portal, secure email, direct message.
- Send one recommendation per problem, with the patient's specific data and a yes/no/alternative response option; a five-item list gets ignored.
- Build a two-week follow-up call into the workflow for non-responders, and record non-response as data so patterns emerge (which offices never reply, and why).
- Offer a short quarterly summary to top prescribers showing accepted recommendations - reciprocity is what converts a fax blast into a working relationship.
3. What metrics would you track monthly to prove the redesign is working, and what would make you conclude the program should be restructured or discontinued?
Read the worked answer
Process metrics:
- CMR completion rate among targeted beneficiaries (baseline 20%).
- Percentage of completed CMRs with a compliant written summary within the required timeframe (baseline ~50%) - this is the contract-protecting number.
- Median days from CMR to summary sent.
- Percentage of scheduled CMRs actually conducted (no-show and unreachable rates separately - they need different fixes).
- Pharmacist minutes per completed CMR.
Outcome metrics:
- Prescriber response rate and recommendation acceptance rate (baseline 14% response).
- Number of medication-related problems identified per CMR and number resolved at 90 days.
- Adherence PDC for the plan's quality measures (e.g., diabetes, RAS antagonist, and statin adherence) - but confirm the current measure set with the plan sponsor each year, because measures are retired and revised.
- ED visits or admissions among reviewed patients, tracked as a trend, not a single-quarter claim.
Discontinuation test: if completion rates rise, summaries are timely, and prescriber acceptance stays flat below roughly 15–20% despite channel changes, the bottleneck is upstream of pharmacy workflow - the program needs a different partner or scope, not more pharmacist hours. Restructure if staff turnover or safety events rise; discontinue only if the plan contract cannot be made to work after a documented redesign cycle.